Impact of treatment of chronic periodontitis on the serum levels of prohepcidin in patients with chronic kidney disease

ISRCTN ISRCTN59866656
DOI https://doi.org/10.1186/ISRCTN59866656
Secondary identifying numbers # 942.248.2006/report # 327/2006
Submission date
07/11/2010
Registration date
18/11/2010
Last edited
03/01/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Eduardo Vilela
Scientific

Rua Dr Geraldo Moutinho 55
Jardins Imperiais
Juiz de Fora
36036348
Brazil

Email eduardo.vilela@ufjf.edu.br

Study information

Study designInterventional controlled clinical assay
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use contact details below to request a patient information sheet.
Scientific titleImpact of treatment of chronic periodontitis on the serum levels of prohepcidin in patients with chronic kidney disease: Interventional controlled clinical assay
Study acronymUFJF
Study objectivesWe hypothesized that part of the chronic inflammatory response seen in chronic kidney disease (CKD) patients stems from chronic periodontitis (CP), which, through the increase in the expression of inflammatory markers such as interleukin-6 (IL-6), stimulates hepcidin synthesis.
Ethics approval(s)Ethics Committee in Research on Human Beings from UFJF approved on the 6th of December 2006 (ref: 942.248.2006 / report: 327/2006)
Health condition(s) or problem(s) studiedChronic periodontitis (CP); chronic kidney disease (CKD); Prohepcidin
InterventionPatients with CP were divided into two groups: CKD patients and controls
Both groups received instructions on oral hygiene techniques, including the manual techniques of tooth and interproximal brushing, and on how to use dental floss and perform supragingival prophylaxis. The nonsurgical periodontal therapy (PT) consisted of radicular scraping and subgingival curettage, using standard instrumentation with Gracey curettes and ultrasound devices performed in 1 hour sessions over an average period of 4 weeks. Local anesthesia was used when necessary.

Upon concluding the periodontal treatment, participants were followed up after 15, 30, 60, and 90 days. At each return visit, instructions on oral hygiene and supragingival phrophylaxis were provided.

Blood samples were collected for biochemical analysis at baseline and 3 months after PT. Venous blood after 12 hours fasting was collected in vacuum tubes between 7:00am and 9:00am. Plasma samples with EDTA/heparin and serum samples were immediately placed in ice, aliquoted within 1 hour and stored at -80C until use.

Results:
The efficacy of PT was proven by the statistically significant decrease in the levels of inflammatory markers and the improvement of clinical parameters of CP observed 3 months after completion of the PT. Prohepcidin, IL-6 and us-PCR levels diminished significantly after PT in both groups. In the control group, besides the decrease in the inflammatory markers, a significant increase could also be observed in the levels of haemoglobin and ferritin associated with PT.
Intervention typeOther
Primary outcome measureInflammatory markers, assessed at baseline and 3 months post-PT
1. C-reactive protein (us-CRP)
2. Interleukin-6 (IL-6)
3. Prohepcidin
Secondary outcome measuresBiochemical analyses from blood sample in EDTA, at baseline and 3 months post-PT
1. Complete haemogram (automated Coulter STKS)
2. Serum iron (ferrozine)
3. Ferritin (electrochemiluminescence)
4. Transferrine saturation index (labtest ferrozine)
Overall study start date10/08/2008
Completion date10/08/2010

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants56
Key inclusion criteria1. Patients with CP, allocated to one of two groups depending on CKD status
1.1. CKD group:
1.1.1. Patients with CKD at stages 3 to 5 and undergoing conservative treatment
1.1.2. Recruited from the PREVENRIM, a CKD prevention clinic at the Interdisciplinary Nucleus of Studies, Research and Treatment in Nephrology (NIEPEN) of the Universidade Federal de Juiz de Fora (UFJF)
1.2. Control patients:
1.2.1. Patients with no systemic disease from the Periodontology Clinic of the School of Dentistry at UFJF
2. Over 18 years of age, either sex
2. Minimum of 20 natural teeth and without periapical lesions
3. Have received no periodontal, antimicrobial, or anti-inflammatory treatment within the last 6 months
4. Have not used steroids or immunosuppressant drugs within the last 6 months
Key exclusion criteria1. Pregnant or breast feeding women
2. Smokers or ex-smokers who had quit smoking within the last 10 years
Date of first enrolment10/08/2008
Date of final enrolment10/08/2010

Locations

Countries of recruitment

  • Brazil

Study participating centre

Rua Dr Geraldo Moutinho 55
Juiz de Fora
36036348
Brazil

Sponsor information

Federal University of Juiz de Fora (Universidade Federal de Juiz de Fora [UFJF]) (Brazil)
University/education

Rua Dr Geraldo Moutinho 55
Jardins Imperiais
Juiz de Fora
36036348
Brazil

ROR logo "ROR" https://ror.org/04yqw9c44

Funders

Funder type

University/education

Federal University of Juiz de Fora (Universidade Federal de Juiz de Fora [UFJF]) (Brazil)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2011 Yes No